EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis of 3‐(Aryl)‐1‐(2‐ p‐ tolylthiazol‐4‐yl)prop‐2‐en‐1‐ones as Alpha(α)‐Amylase Inhibitors

Hafsa Iqbal, Muhammad Haroon iD, Tashfeen Akhtar iD, Aydin Aktaş

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202401021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Hafsa Iqbal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Mirpur University of Science and Technology (MUST), Mirpur (AJK, 10250, Pakistan. Hauptthemen laut MEDLINE: alpha-Amylases, Drug Design, Molecular Docking Simulation, Thiazoles. Die Arbeit nennt 35 Literaturangaben. Gefördert von: HEC Pakistan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α‐Amylase inhibition is vital in controlling diabetic complications. Herein, we have synthesized a hybrid scaffold based on thiazole‐chalcone to access α‐amylase inhbition. The proposed structures were verified with spectroscopic techniques (UV‐Vis., FT‐IR, 1 H‐, 13 C‐NMR, and elemental analysis). The synthesized compounds were evaluated for their α‐amylase and antioxidant potential. In vitro hemolytic assay was performed to test biocompatibility of all compounds. Among tested compounds, 4 c (IC 50 =3.8 μM), 4 g (IC 50 =14.5 μM), and 4 f (IC 50 =17.1 μM) were found excellent α‐amylase inhibitors. However, none of the tested compounds exhibited significant antioxidant activity. All compounds showed less lysis than Triton X‐100, but compounds 4 f and 4 h had the least lysis at all tested concentrations and were found to be safe for human erythrocytes. Molecular docking study was performed to evaluate the binding interactions of ligands with human pancreatic α‐amylase (HPA). The binding score −8.09 to −8.507 kcal/mol revealed strong binding interactions in the ligand‐protein complex. The docking results supplemented the observed α‐amylase inhibition and hence augment the scaffold to serve as leads for the antidiabetic drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-AmylasesDrug DesignMolecular Docking SimulationThiazolesEnzyme InhibitorsHumansStructure-Activity RelationshipMolecular StructureAntioxidantsErythrocytesDose-Response Relationship, Drug

Stichwörter der Autor:innen

AntioxidantCytotoxicityDockingSpectroscopyThiazole-Chalconesα-Amylase inhibition

Substanzen

alpha-AmylasesThiazolesEnzyme InhibitorsAntioxidants

Autor:innen und Institutionen

  • Department of Chemistry, Mirpur University of Science and Technology (MUST), Mirpur (AJK, 10250, Pakistan.
  • Department of Chemistry and Biochemistry, Miami University, 651 E. High Street, Oxford, OH, 45056, USA.
  • Inonu University, Vocational School of Health Service, Malatya, 44280, Türkiye.

ORCID-Profile: Muhammad Haroon, Tashfeen Akhtar

Förderung

  • HEC Pakistan

Zitieren

APA

Iqbal, H., Haroon, M., Akhtar, T., & Aktaş, A. (2024). Design, Synthesis of 3‐(Aryl)‐1‐(2‐ p‐ tolylthiazol‐4‐yl)prop‐2‐en‐1‐ones as Alpha(α)‐Amylase Inhibitors. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401021

Vancouver

Iqbal H, Haroon M, Akhtar T, Aktaş A. Design, Synthesis of 3‐(Aryl)‐1‐(2‐ p‐ tolylthiazol‐4‐yl)prop‐2‐en‐1‐ones as Alpha(α)‐Amylase Inhibitors. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401021

BibTeX
@article{Iqbal2024,
  author = {Iqbal, Hafsa and Haroon, Muhammad and Akhtar, Tashfeen and Aktaş, Aydin},
  title = {Design, Synthesis of 3‐(Aryl)‐1‐(2‐ p‐ tolylthiazol‐4‐yl)prop‐2‐en‐1‐ones as Alpha(α)‐Amylase Inhibitors},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202401021}
}
Kostenlos starten →